Clinicopathological Factors Associated with Incomplete Excision of High-risk Basal Cell Carcinoma
DOI:
https://doi.org/10.2340/00015555-3856Keywords:
basal cell carcinoma, non-melanoma skin cancer, keratinocyte cancer, Mohs micrographic surgery, incomplete excision, risk factorsAbstract
Research has shown higher rates of incomplete excision among high-risk than low-risk basal cell carcinomas, but data is limited. A single-centre, retrospective study including excised high-risk basal cell carcinomas (type II–III according to the Swedish classification) was performed to determine incomplete excision rates and associated clinicopathological risk factors. Overall, 987 consecutive cases were included. Of these, 203 (20.6%) were incompletely excised. Incomplete excision rates were higher for type III basal cell carcinomas (27.0% vs 17.6% for type II, p < 0.001) and localization on the face and scalp (22.4% vs 14.7% for other locations, p = 0.009), especially on the nose, ear, scalp and periorbital area (28.0–37.0% vs 9.5–16.9% for other locations, p < 0.0001). Circular excisions were also more often incomplete (28.5%) compared with elliptical excisions (17.7%) (p < 0.001). No association was found between incomplete excision rates and tumour size, excision margins, use of a preoperative biopsy or surgeon experience. Mohs micrographic surgery should be used more often for type II–III basal cell carcinomas on the face and scalp.
Downloads
References
Kuijpers DI, Thissen MR, Neumann MH. Basal cell carcinoma: treatment options and prognosis, a scientific approach to a common malignancy. Am J Clin Dermatol 2002; 3: 247–259.
Lo JS, Snow SN, Reizner GT, Mohs FE, Larson PO, Hruza GJ. Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J Am Acad Dermatol 1991; 24: 715–719.
Kim JYS, Kozlow JH, Mittal B, Moyer J, Olencki T, Rodgers P. Guidelines of care for the management of basal cell carcinoma. J Am Acad Dermatol 2018; 78: 540–559.
Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 2002; 147: 41–47.
Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med 2015; 88: 167–179.
National Comprehensive Cancer Network, Basal Cell Skin Cancer (Version2.21) 2021. Available from: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1416 .
Jernbeck J, Glaumann B, Glas JE. [Basal cell carcinoma. Clinical evaluation of the histological grading of aggressive types of cancer]. Lakartidningen 1988; 85: 3467–3470 (in Swedish).
Peris K, Fargnoli MC, Garbe C, Kaufmann R, Bastholt L, Seguin NB, et al. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. Eur J Cancer 2019; 118: 10–34.
Telfer NR, Colver GB, Morton CA. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008; 159: 35–48.
Swedish Society for Dermatological Surgery and Oncology (SDKO). [SDKO guidelines for the management of squamous cell carcinoma and basal cell carcinoma] (in Swedish). 2016. Available from: http://ssdv.se/images/pdf/SDKOs_Riktlinjer_for_SCC__BCC_2016.pdf.
Bassas P, Hilari H, Bodet D, Serra M, Kennedy FE, García-Patos V. Evaluation of surgical margins in basal cell carcinoma by surgical specialty. Actas Dermosifiliogr 2013; 104: 133–140.
Kappelin J, Nielsen K, Nilsson F, Bjellerup M, Ahnlide I. Surgical treatment of basal cell carcinoma: a case series on factors influencing the risk of an incomplete primary excision. J Eur Acad Dermatol Venereol 2020; 34: 2518–2525.
Kumar P, Orton CI, McWilliam LJ, Watson S. Incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit. Br J Plast Surg 2000; 53: 563–566.
Codazzi D, Van Der Velden J, Carminati M, Bruschi S, Bocchiotti MA, Di Serio C, et al. Positive compared with negative margins in a single-centre retrospective study on 3957 consecutive excisions of basal cell carcinomas. Associated risk factors and preferred surgical management. J Plast Surg Hand Surg 2014; 48: 38–43.
Kumar P, Watson S, Brain AN, Davenport PJ, McWilliam LJ, Banerjee SS, et al. Incomplete excision of basal cell carcinoma: a prospective multicentre audit. Br J Plast Surg 2002; 55: 616–622.
Su SY, Giorlando F, Ek EW, Dieu T. Incomplete excision of basal cell carcinoma: a prospective trial. Plast Reconstr Surg 2007; 120: 1240–1248.
Ramdas K, van Lee C, Beck S, Bindels P, Noordhoek Hegt V, Pardo L, et al. Differences in rate of complete excision of basal cell carcinoma by dermatologists, plastic surgeons and general practitioners: a large cross-sectional study. Dermatology 2018; 234: 86–91.
Nolan GS, Kiely AL, Totty JP, Wormald JCR, Wade RG, Arbyn M, et al. Br J Dermatol 2021; 184: 1033–1044.
Godoy CAP, Neta ALO, Leao SSS, Dantas RL, Carvalho VOF, Silva SFD. Evaluation of surgical margins according to the histological type of basal cell carcinoma. An Bras Dermatol 2017; 92: 226–230.
Rippey JJ, Rippey E. Characteristics of incompletely excised basal cell carcinomas of the skin. Med J Aust 1997; 166: 581–583.
Farhi D, Dupin N, Palangié A, Carlotti A, Avril MF. Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases. Dermatol Surg 2007; 33: 1207–1214.
Nagore E, Grau C, Molinero J, Fortea JM. Positive margins in basal cell carcinoma: relationship to clinical features and recurrence risk. A retrospective study of 248 patients. J Eur Acad Dermatol Venereol 2003; 17: 167–170.
Dieu T, Macleod AM. Incomplete excision of basal cell carcinomas: a retrospective audit. ANZ J Surg 2002; 72: 219–221.
Duarte B, Vieira L, Pessoa ECT, Ribeiro L, Joao A, Cabete J, et al. Predicting incomplete basal cell carcinoma excisions – a large multidisciplinary retrospective analysis in a tertiary center. J Dermatolog Treat 2020; 31: 583–588.
Sharma AN, Cohen JL, Haupt EC, Sarpa HG, Martin BC. Variables affecting basal cell carcinoma and melanoma in situ excision clearance: a multi-institutional retrospective study. Dermatologic Surgery 2021; 47: 184–188.
Hansen C, Wilkinson D, Hansen M, Soyer HP. Factors contributing to incomplete excision of nonmelanoma skin cancer by Australian general practitioners. Arch Dermatol 2009; 145: 1253–1260.
Bogdanov-Berezovsky A, Cohen AD, Glesinger R, Cagnano E, Krieger Y, Rosenberg L. Risk factors for incomplete excision of basal cell carcinomas. Acta Derm Venereol 2004; 84: 44–47.
Masud D, Moustaki M, Staruch R, Dheansa B. Basal cell carcinomata: risk factors for incomplete excision and results of re-excision. J Plast Reconstr Aesthet Surg 2016; 69: 652–656.
Griffiths RW. Audit of histologically incompletely excised basal cell carcinomas: recommendations for management by re-excision. Br J Plast Surg 1999; 52: 24–28.
Paoli J, Daryoni S, Wennberg AM, Mölne L, Gillstedt M, Miocic M, et al. 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma. Acta Derm Venereol 2011; 91: 689–693.
Kuiper EM, van den Berge BA, Spoo JR, Kuiper J, Terra JB. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: a retrospective study of 1021 cases. Clin Otolaryngol 2018; 43: 1321–1327.
van Loo E, Mosterd K, Krekels GA, Roozeboom MH, Ostertag JU, Dirksen CD, et al. Surgical excision versus Mohs’ micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up. Eur J Cancer 2014; 50: 3011–3020.
Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years. J Am Acad Dermatol 2005; 53: 445–451.
Trakatelli M, Morton C, Nagore E, Ulrich C, Del Marmol V, Peris K, et al. Update of the European guidelines for basal cell carcinoma management. Eur J Dermatol 2014; 24: 312–329.
Murchie P, Delaney EK, Thompson WD, Lee AJ. Excising basal cell carcinomas: comparing the performance of general practitioners, hospital skin specialists and other hospital specialists. Clin Exp Dermatol 2008; 33: 565–571.
Kamyab-Hesari K, Seirafi H, Naraghi ZS, Shahshahani MM, Rahbar Z, Damavandi MR, et al. Diagnostic accuracy of punch biopsy in subtyping basal cell carcinoma. J Eur Acad Dermatol Venereol 2014; 28: 250–253.
Haws AL, Rojano R, Tahan SR, Phung TL. Accuracy of biopsy sampling for subtyping basal cell carcinoma. J Am Acad Dermatol 2012; 66: 106–111.
Messina J, Epstein EH, Jr, Kossard S. Basal cell carcinoma. In: Elder DE, Massi D, Scolyer RA, Willemze R, editors. World Health Organization classification of skin tumours. Lyon, France: IARC Press, 2018; p. 26–34.
Published
How to Cite
License
Copyright (c) 2021 Hannah Ceder, Annie Ekström, Lajla Hadzic, John Paoli
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
